Will Zimmer Biomet stock go up?

According to Danelfin AI, Zimmer Biomet has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (50.21%) is -0.61% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Zimmer Biomet stock?

The Zimmer Biomet target price is $87.29 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Zimmer Biomet stock right now?

Zimmer Biomet has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (50.21%) is -0.61% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Zimmer Biomet stock is a good buy .

Is Zimmer Biomet undervalued right now?

Based on analysts, the average price target upside for Zimmer Biomet is +3.68% (1Y). According to Danelfin AI, Zimmer Biomet has today an AI Score of 4/10 (Hold Rating).

What was the price range of Zimmer Biomet stock over the past 12 months?

The Zimmer Biomet stock price range over the past 12 months has been $79.58 - $107.71.

What is going on with Zimmer Biomet stock in the last 3 months?

The Zimmer Biomet stock performance in the last quarter has been -6.89%.

Does Zimmer Biomet offer dividend payments?

Yes, Zimmer Biomet stock dividend yield is 1.14%.

What is the current market capitalization of Zimmer Biomet?

Zimmer Biomet's market cap is $16.28B, as of 2026-07-02 08:00.

When is the next ZBH earnings report date?

ZBH will publish its next earnings report on 2026-04-28.

Zimmer Biomet Holdings Inc (ZBH) AI Stock Analysis

Advanced Chart

Custom range

Jul 2, 2025

→

Jul 2, 2026

Custom range

Jul 2, 2025

→

Jul 2, 2026

ZBH AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score

Hold

Zimmer Biomet (ZBH) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -0.61% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of ZBH (50.21%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
ZBH probability advantage of beating the market (3M)-0.61%
ZBH probability of beating the market (3M)50.21%

ZBH probability advantage of beating the market (3M): -0.61%

The AI-powered overall analysis of Zimmer Biomet (ZBH) is based on the 28 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of ZBH:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	+2.22%
Technical	Chart Pattern (504d)	figure_76	N/A	-1.74%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	-1.33%
Technical	Technicals Impact (Long Tail)	-	N/A	-1.04%
Fundamental	Net Property, Plant & Equipment (Net PP&E)	2.21K		-1.03%
Sentiment	Sentiment Impact (Long Tail)	-	N/A	+0.80%
Fundamental	Tangible Shareholders' Equity	-1.8K	N/A	+0.63%
Technical	Alpha Last Day	-0.02%		-0.53%
Sentiment	Fear & Greed Index (CNN)	31	N/A	+0.50%
Technical	ATR (14d Volatility)	2.65		+0.47%
Sentiment	Upgrade to unlock			+0.47%
Sentiment	Upgrade to unlock			+0.44%
Sentiment	Upgrade to unlock			-0.41%
Technical	Upgrade to unlock			+0.38%
Fundamental	Upgrade to unlock			-0.34%

Rest of Alpha Signals: -0.11%

ZBH probability advantage of beating the market (3M)Total:-0.61%
ZBH AI Score

Significant changes Vs previous day

ZBH Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$84.19
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

ZBH Proven Hold Signal & Price Forecast

This is the price chart for ZBH from January 1, 2026 until today. The chart indicates, in yellow, the 106 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

ZBH Average Past Performance & Win Rate

Three months after its 1534 Hold signals since July 2026, ZBH had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

1534 Past ZBH Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-1.68%
Average Alpha				-14.73%
Win Rate (% Positive Perf.)				42.37%
% Positive Alpha				24.37%

ZBH Frequently Asked Questions

Will Zimmer Biomet stock go up?
According to Danelfin AI, Zimmer Biomet has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (50.21%) is -0.61% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Zimmer Biomet stock?
Is it a good time to buy, sell, or hold Zimmer Biomet stock right now?
Is Zimmer Biomet undervalued right now?
What was the price range of Zimmer Biomet stock over the past 12 months?
What is going on with Zimmer Biomet stock in the last 3 months?
Does Zimmer Biomet offer dividend payments?
What is the current market capitalization of Zimmer Biomet?
When is the next ZBH earnings report date?

Zimmer Biomet Holdings Inc Company Profile

Zimmer Biomet Holdings, Inc., along with its subsidiaries, functions globally as a premier company in the realm of medical technology. Zimmer Biomet's expertise lies in designing, creating, and marketing a diverse range of orthopedic reconstructive products, exemplified by hip and knee items. Their portfolio also includes S.E.T. products spanning sports medicine, biologics, foot and ankle specialties, extremities and trauma-related offerings.

Additionally, the company has made significant strides in the field of craniomaxillofacial and thoracic merchandise. These encompass groundbreaking products for reconstruction of the face and skull as well as innovative solutions that facilitate healing or reconstruction following open-heart surgery or trauma or remedy deformities of the chest by stabilizing chest bones.

Furthermore, Zimmer Biomet deals with robotic systems, surgical devices and bone cement products. The company’s product suite finds application in treating patients presenting with disorders or injuries affecting bones, joints or soft tissues lending support.

The clientele primarily comprises orthopedic surgeons and neurosurgeons sectors besides hospitals, stocking distributors—healthcare vendors—and other specialists alongside agents—healthcare acquisition organizations—or purchasing groups.

In a strategic move to better embody its expanded capabilities following key acquisitions, Zimmer Holdings reinvented itself as Zimmer Biomet Holdings in June 2015—the most recent chapter in an impressive corporate legacy dating back to 1927.

The company commands operations from their headquarters strategically positioned in Warsaw Indiana—an apt testament to their enduring standing on the global medical technology stage.

Sector:
Country:United States
Industry:
Address:345 E Main St, Warsaw Indiana
Employees:

Pros

High switching costs for orthopedic surgeons

Aging global population driving procedure demand

Regulatory barriers to entry for new competitors

Established global distribution network and surgeon relationships

Continuous product innovation in surgical robotics and digital tools

Cons

Reimbursement pressure from healthcare payers limiting pricing power

Pros

Cons

Company

AI Score

Compare

OBIOOrchestra Biomed Holdings Inc

XTNTXtant Medical Holdings Inc

GMEDGlobus Medical Inc

SIBNSI-BONE Inc

Company

AI Score

Compare

ZBH Top 10 Industry Stocks

Health Care Equipment & Supplies

	Company	AI Score	Compare
1	PODDInsulet Corp
2	UTMDUtah Medical Products Inc
3	PHGKoninklijke Philips NV
4	ALCAlcon AG
5	TMDXTransmedics Group Inc
6	CVRXCVRx Inc
7	GUTSFractyl Health Inc
8	XTNTXtant Medical Holdings Inc
9	ESTAEstablishment Labs Holdings Inc
10	INMDInmode Ltd

	Company	AI Score	Compare

	Company	AI Score	Compare
1	COGTCogent Biosciences Inc

Company

AI Score

Compare

COGTCogent Biosciences Inc

Company

AI Score

Compare

ZBH Stock AI Analysis